Category: Astrazeneca
Science Magazine: Covid vaccines may cause Long Covid–like symptoms
In November 2021, in the New England Journal of Medicine, William Murphy, an immunologist at the University of California, Davis proposed that an autoimmune mechanism triggered by the SARS-CoV-2 spike protein might explain both Long Covid symptoms and some rare vaccine side effects. More...
Italy: 385 Covid deaths and 188,000 new cases in one day despite the harshest restrictions on Earth
Where did it all go wrong for Italy? The pandemic got off to a hideous start in Bergamo, Northern Italy, in 2020, and the country has since gone from one crisis to another in the pandemic. More...
EMA: Transverse Myelitis listed as potential side effect of AstraZeneca and Janssen Covid vaccines
The Europe Medicines Agency has recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca’s and Janssen’s (Johnson and Johnson) COVID-19 vaccines. More...
UK: Covid-19 infections, hospitalizations and deaths by vaccination status for week 2, 2022
A new report out today by the UK Health and Security Agency gives figures for Covid infections, hospitalizations and deaths by vaccination status for the period in which Omicron became dominant in Britain. More...
EMA: Immune system could be overloaded by booster vaccinations
The European Medicines Agency warned this week that repeated booster shots are not a sustainable long-term plan. More...
Is Sars-CoV-2 already targeting the vaccinated?
Will future variants of Sars-Cov-2 tailor themselves to target the vaccinated? More...
ICU doctor to UK Health Secretary: “I do not want to have a vaccination” *3 UPDATES*
Steve James, a consultant anaesthetist at King’s College Hospital in London who has worked in the ICU since early 2020 treating Covid patients, told UK Health Secretary Sajid Javid why he did not believe in vaccination. More...
UKHSA: Vaccine effectiveness drops to just 40% – 50% ten weeks after booster dose
Two to 4 weeks after a booster dose, vaccine effectiveness ranged from around 65% to 75%, dropping to 55% to 70% at 5 to 9 weeks and 40% to 50% from 10+ weeks after the booster. More...
UK.GOV: Vaccine booster doses wane after just 10 weeks
“The latest data suggests this extra protection starts to wane more rapidly, being about 15 to 25% lower from 10 weeks after the booster dose.” More...
Imperial College: Omicron is NOT milder than Delta
“We find no evidence (for both risk of hospitalisation attendance and symptom status) of Omicron having different severity from Delta, though data on hospitalisations are still very limited… Omicron was associated with a 5.41 fold higher relative risk of reinfection compared with Delta.” More...